How does sharewise work?
Discuss
Discuss and share predictions for your favorite stocks in the forum. Let your opinion be heard
Show moreTop Buy/Sell (This Month)
| Security | Price | Target price |
|---|---|---|
| Microsoft Corp. | €416.20 | €500.91 |
| Amazon.com Inc. | €224.25 | €258.70 |
| Alphabet Inc. C | €295.05 | €367.50 |
| Security | Price | Target price |
|---|---|---|
| Clorox Co. | €91.40 | €91.19 |
| Western Union Co. | €6.23 | €6.07 |
| Socket Mobile Inc. | ? | - |
New Top predictions since last week
| Prediction | User | Perf. (%) |
|---|---|---|
| B Tvardi Therapeutics Inc. | quelbe60 | 39.42% |
| B EyePoint Pharmaceuticals Inc. | Kryptonit | 22.92% |
| B EyePoint Pharmaceuticals Inc. | Chardan Capital | 19.80% |
| Prediction | User | Perf. (%) |
|---|---|---|
| S Capricor Therapeutics Inc | Bankster | -22.55% |
| S Socket Mobile Inc. | blaugold | -18.52% |
| S Applied Optoelectronics Inc. | Bankster | -14.97% |
Portfolios of our members
OP Research
When it comes to stocks, what is important for you?
Find stocks based on your criteria with our sharewise stock finder. All results are based on thousands of votes by our community
Pros and Cons of these stocks (New Predictions)
EyePoint Pharmaceuticals Inc.
WKN: A2QJRU / Symbol: EYPT / Name: EyePoint Pharma / Stock / Biotechnology & Medical Research / Small Cap /
Pros
Cons
Try sharewise+ and get hundreds more matching stocks
Sign up for free!Tops & Flops S&P 500
| Security | Price | Change(%) (%) |
|---|---|---|
| Targa Resources Corp. | €257.30 | 7.500% |
| Bath & Body Works Inc. | €17.35 | 6.840% |
| Insulet Corp. | €128.00 | 5.970% |
| Carnival Paired Ctf | €23.45 | 5.850% |
| Discovery Communications C | €22.42 | 5.110% |
| Security | Price | Change(%) (%) |
|---|---|---|
| Ciena Corp. | €350.10 | -10.120% |
| Lumentum Holdings Inc | €754.20 | -9.910% |
| Teradyne Inc. | €348.75 | -9.360% |
| Sandisk Corp. | €1,410.0 | -9.030% |
| Seagate Technology.Holdings plc | €782.00 | -8.600% |
Courses
Key figures for stocks
sharewise Introduction
Predictions
EyePoint Pharmaceuticals Inc.
18:15
18.08.27
14.08.26
Top News
The AI Boom Is Turning This Cable Maker Into a Stock to Watch
Key Points
- Interested in Belden Inc? Here are five stocks we like better.
- Belden is not a chipmaker, but its connectivity products are becoming more relevant as AI data centers expand.
- The
APA Targets $700M Cost Cuts, 5% Oil Growth as Suriname Project Nears 2028 Start
Key Points
- Interested in APA Corporation? Here are five stocks we like better.
- APA expects roughly $700 million in lower annual cash costs by 2027, including $500 million in structural savings
A Star Investor Just Trimmed Amazon—Here's What It means
Key Points
- Interested in Amazon.com, Inc.? Here are five stocks we like better.
- Dan Loeb's Third Point trimmed its Amazon stake by roughly 10%, but the fund still holds it as a top position
Wendy’s Deal Buzz May Give Fast-Food Investors a New Reason to Look
Key Points
- Interested in The Wendy's Company? Here are five stocks we like better.
- Rumors that Trian Fund Management may take Wendy's private have driven WEN shares up 15% in five days despite no
Applied Optoelectronics Bets on U.S. Laser Capacity to Capture AI Data Center Demand
Key Points
- Interested in Applied Optoelectronics, Inc.? Here are five stocks we like better.
- Laser capacity is Applied Optoelectronics’ main constraint as demand grows for AI data centers and
U.S.-China 2026 Tech Race: 2 AI Stocks & 2 Quantum Stocks to Watch
The U.S.-China technology race is increasingly becoming a contest over artificial intelligence, quantum computing, semiconductors, critical minerals and control of strategic technology supply
Ecolab's CoolIT Deal Raises AI Upside but Also Debt and Cost Risks
Ecolab Inc. ECL has expanded its artificial intelligence infrastructure exposure with the $4.75 billion acquisition of CoolIT Systems. The deal gives Ecolab a larger role in data-center cooling as
News
Is Ecolab Stock Worth Buying as Growth Rises but Debt Risk Builds?
Ecolab Inc. ECL is delivering faster growth across High-Tech, Digital and Life Sciences while pricing and productivity support profitability. The question for investors is whether those improving
Digital Turbine Jumps 208% in a Year: Is the Stock Worth Buying Now?
Shares of Digital Turbine Inc. APPS have risen a whopping 208.3% over the past year, outperforming the Zacks Internet – Software industry's decline of 10%. The company has also outpaced the Computer
Ecolab Rallies 12.2% in 3 Months as High-Tech Growth Gains Momentum
Ecolab Inc. ECL shares have gained 12.2% over the past three months, drawing attention to whether improving operating momentum can sustain the advance.
Faster growth in High-Tech, Digital and Life
Is Gilead's Expanding HIV Portfolio a Growth Catalyst?
Gilead Sciences, Inc. GILD has a market-leading HIV franchise, led by flagship HIV therapies — Biktarvy for treatment and Descovy for prevention.
Earlier this month, the company reported
VF Corp. Raises Fiscal 2027 Sales Outlook as Outdoor Growth Offsets Vans
VF Corporation VFC raised its fiscal 2027 constant-currency revenue outlook to growth of 2% or better, up from its previous 1-2% range, after first-quarter performance exceeded management’s revenue
SBH Q3 Results Pair Margin Gains With a Tighter 2026 Sales Outlook
Sally Beauty Holdings, Inc. SBH posted fiscal third-quarter 2026 adjusted earnings of 55 cents per share, beating the Zacks Consensus Estimate of 53 cents. Net sales edged up 0.2% to $935.5 million
What IREN's Microsoft Delivery Means for Its $9.7 Billion AI Pivot
Microsoft's acceptance of Horizon 1 gives IREN Limited IREN a tangible proof point in its effort to convert a five-year, $9.7 billion AI agreement into operating infrastructure. The milestone moves
Should Investors Buy IREN as AI Growth Meets a Premium Valuation?
IREN Limited IREN is accelerating its shift from Bitcoin mining to AI cloud infrastructure, with contracted demand, secured power and new capacity supporting a much larger revenue base. AI Cloud
Is VFC Worth Buying as Cheap Valuation Meets Vans Execution Risk?
VF Corporation VFC presents a classic turnaround trade-off: its valuation sits below both industry benchmarks and its own historical norm, while operating progress at The North Face, Timberland and
Contest
Still running
Heibel Ticker
sharewise sagt: Stephan Heibel ist ein langähriger Unterstützer und Autor der Wunschanalyse. Er betreibt meiner Meinung nach einen der besten Börsenbriefe. Es gibt eine kostenlose und eine Premium Variante.
Kostenlos ausprobieren
Leeway
Die Analyse-Plattform Leeway untersucht mit KI-unterstützten Algorithmen aussagekräftige Zusammenhänge am Aktienmarkt. Anhand von vielen Millionen Datenpunkten finden die Algorithmen die Kennzahlen und Bewegungen, die nachweisbare Auswirkungen haben und Vorteile schaffen.
Kostenlos ausprobierensharewise
Du findest das sharewise Projekt spannend und möchtest es unterstützen?
Mit einer
sharewise+-Mitgliedschaft
unterstützt du uns finanziell und bekommst zusätzliche Funktionalitäten freigeschalten.
sharewise
Du findest das sharewise Projekt spannend und möchtest es unterstützen?
Mit einer
sharewise+-Mitgliedschaft
unterstützt du uns finanziell und bekommst zusätzliche Funktionalitäten freigeschalten.










